FGL (Fibroblast Growth-Like) vs GHK-Cu

Overview

FGL (Fibroblast Growth-Like) is primarily a healing & recovery peptide, while GHK-Cu is used for pain management.

This page compares FGL (Fibroblast Growth-Like) and GHK-Cu across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. FGL (Fibroblast Growth-Like) is categorised under Healing & Recovery, while GHK-Cu falls under Pain Management. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. FGL (Fibroblast Growth-Like): not FDA-approved; treated as a research compound. GHK-Cu: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. FGL (Fibroblast Growth-Like) is typically dosed at 1 mg (daily). GHK-Cu is typically dosed at 1-3 mg (daily).

Can you stack them?

Some protocols combine peptides, but stacking FGL (Fibroblast Growth-Like) and GHK-Cu has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between FGL (Fibroblast Growth-Like) and GHK-Cu?

FGL (Fibroblast Growth-Like) is primarily a healing & recovery peptide, while GHK-Cu is used for pain management. FGL (Fibroblast Growth-Like) is not FDA-approved; generally classified as a research compound, whereas GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026).

What is FGL (Fibroblast Growth-Like) used for?

Neural repair peptide.

What is GHK-Cu used for?

Anti-inflammatory tissue repair.

Can you take FGL (Fibroblast Growth-Like) and GHK-Cu together?

Some users combine peptides within a single protocol, but stacking FGL (Fibroblast Growth-Like) and GHK-Cu has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is FGL (Fibroblast Growth-Like) or GHK-Cu FDA-approved?

FGL (Fibroblast Growth-Like) is not FDA-approved; generally classified as a research compound. GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026).